Resmed Inc

The stock has a good momentum. Resmed Inc is not very popular among insiders. Resmed Inc is a mediocre stock to choose.

ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equip...

News

ResMed Inc. (NYSE:RMD) CFO Sells $246,420.00 in Stock

Ticker Report ResMed Inc. (NYSE:RMD - Get Free Report) CFO Brett Sandercock sold 1,000 shares of ResMed stock in a transaction on Monday, September 9th. The stock was sold at an average price of $246.42, for a...\n more…

ResMed Inc. (NYSE:RMD) CEO Sells $3,646,963.54 in Stock

Zolmax ResMed Inc. (NYSE:RMD - Get Free Report) CEO Michael J. Farrell sold 14,683 shares of ResMed stock in a transaction on Monday, September 9th. The shares were sold at an average price of $248.38, for...\n more…

Michael J. Farrell Sells 14,683 Shares of ResMed Inc. (NYSE:RMD) Stock

Ticker Report ResMed Inc. (NYSE:RMD - Get Free Report) CEO Michael J. Farrell sold 14,683 shares of the company's stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average...\n more…

ResMed Inc. (NYSE:RMD) Shares Purchased by Candriam S.C.A.

Ticker Report Candriam S.C.A. increased its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 10.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...\n more…

Candriam S.C.A. Boosts Holdings in ResMed Inc. (NYSE:RMD)

Zolmax Candriam S.C.A. increased its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 10.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The...\n more…

ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange

Globe Newswire Learn more about ResMed's 2030 strategy to accelerate growthJoin in person or via virtual webcast SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an...\n more…